About Ripharma Laboratories Limited
Data last updated: 17 January 2026
Ripharma Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 25 March 2015, the company has been in operation for over 11 years.
Registered with ROC Mumbai under CIN U24100MH2015PLC262970.
Capital: an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Rishabh Shreepal Jain and Shantilal Rajmal Jain.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 144 Behram Mahal 534 Kalbadevi Road Near Edward Cinema, Mumbai, Maharashtra, India – 400002.
As per the financials filed for FY 2025, the company reported a revenue of ₹66 Cr, a growth of 138% compared to the previous year.
The company is associated with 1 brand - Ripharma. As per MCA filings, the company has open charges of ₹4.9 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ripharma.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address144 Behram Mahal 534 Kalbadevi Road Near Edward Cinema, Mumbai, Maharashtra, India – 400002
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Ripharma Laboratories Limited
Ripharma Laboratories Limited operates one associated brand: Ripharma. These brands represent Ripharma Laboratories Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical discovery, development, and delivery in India. | ripharma.in |
Business Activity of Ripharma Laboratories Limited
Ripharma Laboratories Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details for Ripharma Laboratories Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Ripharma Laboratories Limited
Ripharma Laboratories Limited is audited by NPV & Associates LLP for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NPV & Associates LLP | Locked | Locked | Locked |
Complete auditor history for Ripharma Laboratories Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ripharma Laboratories Limited
Ripharma Laboratories Limited is currently managed by 6 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rishabh Shreepal Jain | Director | 25 Mar 2015 | 11 Years 4 Months | Current |
|
Shantilal Rajmal Jain
Also directs:
Raja-Nava Developers Pvt Ltd, Skyline Construtech Private Limited
|
Director | 04 Feb 2025 | 1 Years 6 Months | Current |
|
Shreepal Champalal Jain
Also directs:
Skyline Construtech Private Limited, Rishabh Indotex Limited
|
Director | 25 Mar 2015 | 11 Years 4 Months | Current |
|
Shrenik Champalal Jain
Also directs:
Skyline Construtech Private Limited, Rishabh Indotex Limited
|
Director | 25 Mar 2015 | 11 Years 4 Months | Current |
|
Milan Champalal Jain
Also directs:
Skyline Construtech Private Limited, Rishabh Indotex Limited
|
Director | 25 Mar 2015 | 11 Years 4 Months | Current |
| Amit Shantilal Jain | Director | 25 Mar 2015 | 11 Years 4 Months | Current |
Financials of Ripharma Laboratories Limited FY 2025 filings available
Ripharma Laboratories Limited reported revenue of ₹66 Cr (up 138.00% YoY) for FY 2025.
Ten-year financial statements for Ripharma Laboratories Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Ripharma Laboratories Limited
Shareholding and ownership data for Ripharma Laboratories Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ripharma Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jan 2025 | Others | ₹4.9 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Ripharma Laboratories Limited
View historical data on people associated with Ripharma Laboratories Limited, including employment history and EPFO contributions.
Employee and EPFO history for Ripharma Laboratories Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Ripharma Laboratories Limited
GST registrations and filing compliance for Ripharma Laboratories Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Ripharma Laboratories Limited
Credit ratings, litigation, and regulatory alerts for Ripharma Laboratories Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ripharma Laboratories Limited
MSME payment history for Ripharma Laboratories Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ripharma Laboratories Limited
Corporate group structure for Ripharma Laboratories Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ripharma Laboratories Limited
MCA filings and documents for Ripharma Laboratories Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Ripharma Laboratories Limited
Frequently Asked Questions about Ripharma Laboratories Limited
Ripharma Laboratories Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 25 March 2015 (11+ years old) and is registered under CIN U24100MH2015PLC262970.
Ripharma Laboratories Limited reported revenue of ₹66 Cr for FY 2025 (up 138.00% YoY).
The current directors of Ripharma Laboratories Limited are:
- Rishabh Shreepal Jain - Director
- Shantilal Rajmal Jain - Director
- Shreepal Champalal Jain - Director
- Shrenik Champalal Jain - Director
- Milan Champalal Jain - Director
- Amit Shantilal Jain - Director
The primary industry of Ripharma Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Ripharma Laboratories Limited can be reached at the registered office: 144 Behram Mahal 534 Kalbadevi Road Near Edward Cinema, Mumbai, Maharashtra, India – 400002, or through the website ripharma.in.
The authorised capital is ₹5 Lakh, and the paid-up capital is ₹5 Lakh.